Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,873
Closed -$302K 1269
2025
Q4
$302K Sell
2,873
-1,321
-31% -$124K 0.02% 1201
2025
Q3
$352K Buy
4,194
+435
+12% +$35.8K 0.02% 1048
2025
Q2
$298K Sell
3,759
-15,516
-80% -$1.23M 0.03% 882
2025
Q1
$1.73M Buy
19,275
+7,639
+66% +$713K 0.19% 135
2024
Q4
$1.16M Buy
11,636
+1,239
+12% +$128K 0.15% 198
2024
Q3
$1.18M Sell
10,397
-7,272
-41% -$864K 0.11% 302
2024
Q2
$2.19M Buy
17,669
+6,013
+52% +$775K 0.3% 69
2024
Q1
$1.54M Buy
11,656
+7,263
+165% +$895K 0.27% 112
2023
Q4
$479K Buy
+4,393
New +$456K 0.1% 358

Other funds holding MRK

AlphaQuest's MRK Position: Q1 2026 in Review

AlphaQuest sold out of Merck (MRK) in Q1 2026, closing a stake of 2,873 shares — an estimated $302K sold.

AlphaQuest first reported a position in MRK in Q4 2023 and held it in 9 quarters. The position peaked at $2.19M in Q2 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • AlphaQuest reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 2,873 Merck shares in Q1 2026, an estimated $302K.
  • AlphaQuest first reported a position in Merck in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Merck position peaked at $2.19M in Q2 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.